Marshall Wace, LLP Axonics, Inc. Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

A detailed history of Marshall Wace, LLP transactions in Axonics, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 125,608 shares of AXNX stock, worth $8.92 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

125,608

Previous 128,321 2.11%

Holding current value

$8.92 Million

Previous $8.63 Million 1.44%

% of portfolio

0.01%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$67.3 - $69.67 $182,584 - $189,014	-2,713 Reduced 2.11%	125,608 $8.75 Million
Q2 2024 Aug 14, 2024	SELL	$66.47 - $69.65 $1.97 Million - $2.06 Million	-29,589 Reduced 18.74%	128,321 $8.63 Million
Q1 2024 May 15, 2024	BUY	$56.67 - $69.36 $8.95 Million - $11 Million	157,910 New	157,910 $10.9 Million
Q3 2023 Nov 14, 2023	SELL	$48.64 - $62.51 $35.3 Million - $45.3 Million	-725,279 Reduced 82.61%	152,686 $8.57 Million
Q2 2023 Aug 14, 2023	BUY	$47.99 - $60.21 $4.3 Million - $5.39 Million	89,553 Added 11.36%	877,965 $44.3 Million
Q1 2023 May 15, 2023	BUY	$52.6 - $67.34 $8.54 Million - $10.9 Million	162,277 Added 25.92%	788,412 $43 Million
Q4 2022 Feb 14, 2023	SELL	$59.56 - $76.6 $12.4 Million - $15.9 Million	-207,946 Reduced 24.93%	626,135 $39.2 Million
Q3 2022 Nov 14, 2022	BUY	$57.96 - $78.12 $18.5 Million - $25 Million	319,388 Added 62.05%	834,081 $58.8 Million
Q2 2022 Aug 15, 2022	SELL	$39.5 - $64.42 $20 Million - $32.7 Million	-507,339 Reduced 49.64%	514,693 $29.2 Million
Q1 2022 May 16, 2022	BUY	$43.74 - $62.76 $14.3 Million - $20.6 Million	327,700 Added 47.2%	1,022,032 $64 Million
Q4 2021 Feb 14, 2022	BUY	$50.01 - $73.35 $34.7 Million - $50.9 Million	694,332 New	694,332 $38.9 Million

Others Institutions Holding AXNX

# of Institutions

221

Shares Held

42M

Call Options Held

83.4K

Put Options Held

65.3K

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Axonics, Inc. Transaction History